INNT
TOTAL INVALIDATION PROCESSED BY THE IB
02/12/2026
Back to search
Official data from USPTO
EYED PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EYED PHARMA
ST13
US500000079193685Class
5, 10, 42
Filing
79193685
Registration
5466623
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
53
Latest update
02/13/2026
Trademark type
Word
Nice classes
5, 10, 42
Filing date
08/16/2016
Registration date
05/15/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/29/2024
Last transaction
02/13/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
33
Owner location
BE
Examiner
BLAZICH, JOAN MICHELE
Law office
N40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Eyed Pharma, S.A.
Representatives
Clifford D. Hyra Fresh IP PLC
Technical classification
Nice Classes
Class 5Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticalveterinarymedicinal products and preparations for the treatment of ophthalmologic diseases and disorders; Ophthalmic preparations for the treatment of eye diseases and conditions; Topical antiseptic substances for the treatment of infections of the eyes; Lotion for eyes and Ophthalmic ointment for medical purposes; Eye packspads and plasters for medical use; All of the aforementioned excluding dietary supplements
Class 10
Medical and veterinary apparatus and instrumentation for the treatment of ophthalmologic diseases and disorders; Intraocular implants made of artificial materials and devicessqueeze and drop dispensers for slowly dispensing ophthalmic and pharmaceutical preparations; Artificial lenses for surgical implantation in the eye
Class 42
Scientific research and technological development in the field of ophthalmic and pharmaceutical preparationsdevices and instruments
Publications
History of USPTO decisions and trademark events.
53 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
01/24/2026
INPC
INVALIDATION PROCESSED
01/24/2026
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
07/29/2025
C71T
CANCELLED SECTION 71
11/29/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/18/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/03/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/15/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/01/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
01/01/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/01/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/01/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/04/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/16/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/07/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/05/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/14/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/23/2018
FIMP
FINAL DISPOSITION PROCESSED
08/23/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/15/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
05/15/2018
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/30/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/14/2018
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/14/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/27/2018
PUBO
PUBLISHED FOR OPPOSITION
02/27/2018
GPNX
NOTIFICATION PROCESSED BY IB
02/23/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/07/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/07/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/07/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/19/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/11/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/11/2018
ALIE
ASSIGNED TO LIE
01/10/2018
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
12/22/2017
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
06/15/2017
GNSL
LETTER OF SUSPENSION E-MAILED
06/15/2017
CNSL
SUSPENSION LETTER WRITTEN
06/15/2017
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
05/09/2017
GNSL
LETTER OF SUSPENSION E-MAILED
05/09/2017
CNSL
SUSPENSION LETTER WRITTEN
05/09/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/03/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/03/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/03/2017
RFNT
REFUSAL PROCESSED BY IB
12/17/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/01/2016
RFRR
REFUSAL PROCESSED BY MPU
12/01/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/01/2016
CNRT
NON-FINAL ACTION WRITTEN
11/30/2016
DOCK
ASSIGNED TO EXAMINER
11/29/2016
MAFR
APPLICATION FILING RECEIPT MAILED
10/22/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/18/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/17/2016
Continuous trademark protection
Get notified about every new filing that threatens EYED PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.